Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
INDV

Market Cap: $4.3B

II

Indivior Pharmaceuticals Inc

INDV

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin83.86%

EBITDA Margin32.43%

EBIT Margin31.53%

Pre-tax Margin29.50%

Net Profit Margin26.65%

Earnings Yield8.21%

Valuation Multiples

Price / Book-20.79

Price / Sales3.23

Price / Earnings12.14

PEG0.07

Forward PEG1.29

EV / Sales3.45

EV / EBITDA10.63

EV / Operating Cash Flow-114.76

EV / Free Cash Flow-41.35

Price / Free Cash Flow-38.77

Price / Operating Cash Flow-108.08

Cash Flow & Capital

Free Cash Flow / Share-$0.89

Operating Cash Flow / Share-$0.32

Free Cash Flow Yield-2.58%

Capex / Revenue5.33%

Capex / Operating Cash Flow-1.77%

Capex / Depreciation4.18

Stock Compensation / Revenue2.40%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio0.84

Quick Ratio0.66

Cash Ratio0.26

Debt / Assets0.41

Debt / Capital1.69

Debt / Equity-2.45

Long-Term Debt / Capital1.75

Debt / Market Cap11.53%

Net Debt / EBITDA0.66

Solvency Ratio0.25

Financial Leverage-5.93

Efficiency & Working Capital

Asset Turnover1.08

Fixed Asset Turnover7.28

Inventory Turnover1.43

Receivables Turnover4.64

Payables Turnover7.17

Days Sales Outstanding78.64

Days Inventory Outstanding254.65

Days Payables Outstanding50.93

Operating Cycle333.3

Cash Conversion Cycle282.37

Working Capital Turnover-10.45

Returns & Quality

Return on Equity-2.16%

Return on Assets28.79%

Return on Invested Capital1.25%

ROCE1.42%

Return on Tangible Assets28.84%

Operating Return on Assets42.63%

Income Quality-0.11

Tax Burden0.90

Interest Burden0.94

Balance Sheet & Intrinsic Metrics

Enterprise Value$4.59B

Invested Capital$42M

Working Capital$-143M

Tangible Asset Value$-210M

Net Current Asset Value$-716M

Graham Net-Net-$7.41

Book Value / Share-$1.66

Tangible Book Value / Share-$1.68

Cash / Share$1.77

Financial Health Scores

Piotroski Score4

Altman Z-Score3.48

Revenue$1.33B

EBIT$420M

Market Cap$4.31B

Working Capital$-143M

Retained Earnings$-334M

Total Assets$1.23B

Total Liabilities$1.44B